HEICO Corporation (HEI) Stock Forecast
Data as of May 2, 2026Industrials · Current price $269.25 (-0.25%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 23, 2026 | Charles Minervino | Susquehanna | $385.00 | +43.0% |
| Dec 22, 2025 | Scott Deuschle | Deutsche Bank | $375.00 | +39.3% |
| Dec 22, 2025 | Ken Herbert | RBC Capital | $375.00 | +39.3% |
| Aug 27, 2025 | Noah Poponak | Goldman Sachs | $382.00 | +41.9% |
| Aug 27, 2025 | Ken Herbert | RBC Capital | $350.00 | +30.0% |
| Aug 26, 2025 | Jonathan Siegmann | Stifel Nicolaus | $360.00 | +33.7% |
| Jun 2, 2025 | David Strauss | Barclays | $280.00 | +4.0% |
| Jan 2, 2025 | Scott Deuschle | Deutsche Bank | $265.00 | -1.6% |
| Dec 19, 2024 | Scott Deuschle | Deutsche Bank | $266.00 | -1.2% |
| Oct 18, 2024 | Michael Ciarmoli | Truist Financial | $282.00 | +4.7% |
| Sep 19, 2024 | Ronald Epstein | Bank of America Securities | $285.00 | +5.9% |
| Sep 4, 2024 | Scott Deuschle | Deutsche Bank | $271.00 | +0.7% |
| Aug 28, 2024 | Ken Herbert | RBC Capital | $272.00 | +1.0% |
| Aug 28, 2024 | Peter Arment | Robert W. Baird | $280.00 | +4.0% |
| Aug 27, 2024 | Michael Ciarmoli | Truist Financial | $264.00 | -1.9% |
| Aug 23, 2024 | David Strauss | Barclays | $250.00 | -7.1% |
| Aug 23, 2024 | Michael Ciarmoli | Truist Financial | $248.00 | -7.9% |
| Aug 14, 2024 | Sheila Kahyaoglu | Jefferies | $275.00 | +2.1% |
| Jun 4, 2024 | Kristine Liwag | Morgan Stanley | $225.00 | -16.4% |
| May 30, 2024 | Michael Ciarmoli | Truist Financial | $240.00 | -10.9% |
Top Analysts Covering HEI
HEI vs Sector & Market
| Metric | HEI | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.14 | 2.41 | 2.41 |
| Analyst Count | 7 | 8 | 18 |
| Target Upside | +37.8% | +84.9% | +14.9% |
| P/E Ratio | 53.21 | 28.12 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-10-31 | $4.96B | $5.07B | $5.17B | 17 |
| 2027-01-31 | $1.29B | $1.32B | $1.37B | 7 |
| 2027-04-30 | $1.34B | $1.37B | $1.43B | 6 |
| 2027-07-31 | $1.40B | $1.43B | $1.50B | 7 |
| 2027-10-31 | $1.45B | $1.49B | $1.55B | 7 |
| 2028-01-31 | $1.41B | $1.44B | $1.51B | 10 |
| 2028-04-30 | $1.48B | $1.51B | $1.58B | 9 |
| 2028-07-31 | $1.54B | $1.58B | $1.65B | 10 |
| 2028-10-31 | $1.58B | $1.62B | $1.69B | 10 |
| 2029-10-31 | $5.90B | $6.06B | $6.28B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-10-31 | $5.45 | $5.61 | $5.79 | 16 |
| 2027-01-31 | $1.43 | $1.47 | $1.56 | 6 |
| 2027-04-30 | $1.48 | $1.53 | $1.62 | 5 |
| 2027-07-31 | $1.57 | $1.62 | $1.71 | 6 |
| 2027-10-31 | $1.65 | $1.70 | $1.80 | 6 |
| 2028-01-31 | $1.65 | $1.70 | $1.79 | 11 |
| 2028-04-30 | $1.72 | $1.78 | $1.88 | 10 |
| 2028-07-31 | $1.87 | $1.93 | $2.04 | 11 |
| 2028-10-31 | $1.95 | $2.01 | $2.12 | 11 |
| 2029-10-31 | $7.26 | $7.52 | $7.87 | 4 |
Frequently Asked Questions
What is the analyst consensus for HEI?
The consensus among 7 analysts covering HEICO Corporation (HEI) is Buy with an average price target of $371.00.
What is the highest price target for HEI?
The highest price target for HEI is $385.00, set by Charles Minervino at Susquehanna on 2026-01-23.
What is the lowest price target for HEI?
The lowest price target for HEI is $140.00, set by Robert Stallard at Vertical Research on 2021-05-26.
How many analysts cover HEI?
7 analysts have issued ratings for HEICO Corporation in the past 12 months.
Is HEI a buy or sell right now?
Based on 7 analyst ratings, HEI has a consensus rating of Buy (2.14/5) with a +37.8% upside to the consensus target of $371.00.
What are the earnings estimates for HEI?
Analysts estimate HEI will report EPS of $5.61 for the period ending 2026-10-31, with revenue estimated at $5.07B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.